Skip to Content

View Additional Section Content

AGCT1531 – A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs Cisplain for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/record/NCT03067181?term=AGCT1531&rank=1

Clinical Trial Categories

  • Germ Cell Tumors
Contact
Hanjani Institute for Gynecologic Oncology at 215-885-0220

Location

  • Hanjani Institute for Gynecologic Oncology
    The Rosenfeld Cancer Center
    1200 Old York Rd, AMH - 1 Widener
    Abington, PA 19001
    Office: 215-885-0220
    Fax: 215-576-0740

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM